Suppr
超能文献

New emerging SARS-CoV-2 variants and antiviral agents.

作者信息

Vitiello A, Zovi A, Rezza G

机构信息

Ministry of Health, Directorate-General for Health Prevention, Viale Giorgio Ribotta 5, 00144, Rome, Italy.

Ministry of Health, Viale Giorgio Ribotta 5, 00144 Rome, Italy.

出版信息

Drug Resist Updat. 2023 Sep;70:100986. doi: 10.1016/j.drup.2023.100986. Epub 2023 Jun 26.

DOI:10.1016/j.drup.2023.100986

PMID:37390619

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10292910/

Abstract

摘要

相似文献

New emerging SARS-CoV-2 variants and antiviral agents.

Drug Resist Updat. 2023 Sep;70:100986. doi: 10.1016/j.drup.2023.100986. Epub 2023 Jun 26.

A hijack mechanism of Indian SARS-CoV-2 isolates for relapsing contemporary antiviral therapeutics.

Comput Biol Med. 2021 May;132:104315. doi: 10.1016/j.compbiomed.2021.104315. Epub 2021 Mar 6.

No shortcuts to SARS-CoV-2 antivirals.

Science. 2021 Jul 30;373(6554):488-489. doi: 10.1126/science.abj9488.

SARS-CoV-2 rebound with and without antivirals.

Lancet Infect Dis. 2023 Jun;23(6):637-639. doi: 10.1016/S1473-3099(23)00063-4. Epub 2023 Feb 13.

Antiviral Therapy of COVID-19.

Int J Mol Sci. 2023 May 16;24(10):8867. doi: 10.3390/ijms24108867.

Oral antiviral treatments for COVID-19: opportunities and challenges.

Pharmacol Rep. 2022 Dec;74(6):1255-1278. doi: 10.1007/s43440-022-00388-7. Epub 2022 Jul 25.

Broad-Spectrum Antivirals Derived from Natural Products.

Viruses. 2023 Apr 30;15(5):1100. doi: 10.3390/v15051100.

Liposomal Lactoferrin Exerts Antiviral Activity against HCoV-229E and SARS-CoV-2 Pseudoviruses In Vitro.

Viruses. 2023 Apr 15;15(4):972. doi: 10.3390/v15040972.

β-Cyclodextrins as affordable antivirals to treat coronavirus infection.

Biomed Pharmacother. 2023 Aug;164:114997. doi: 10.1016/j.biopha.2023.114997. Epub 2023 Jun 8.

Antiviral Effect of Budesonide against SARS-CoV-2.

Viruses. 2021 Jul 20;13(7):1411. doi: 10.3390/v13071411.

引用本文的文献

Screening and identification of host factors interacting with the nucleocapsid protein of SARS-CoV-2 omicron variant using the yeast two-hybrid system.

BMC Microbiol. 2025 Aug 1;25(1):474. doi: 10.1186/s12866-025-04226-7.

Identification of compounds targeting porcine reproductive and respiratory syndrome virus nsp3 and evaluation of their antiviral efficacy.

Virulence. 2025 Dec;16(1):2530176. doi: 10.1080/21505594.2025.2530176. Epub 2025 Jul 6.

Identification of biomarkers in Alzheimer's disease and COVID-19 by bioinformatics combining single-cell data analysis and machine learning algorithms.

PLoS One. 2025 Feb 18;20(2):e0317915. doi: 10.1371/journal.pone.0317915. eCollection 2025.

Therapeutic Strategies to Combat Increasing Rates of Multidrug Resistant Pathogens.

Pharm Res. 2024 Aug;41(8):1557-1571. doi: 10.1007/s11095-024-03756-5. Epub 2024 Aug 6.

A Phase 3, Randomized, Controlled Trial Evaluating the Efficacy and Safety of Ropeginterferon Alfa-2b in Patients with Moderate COVID-19.

Infect Dis Ther. 2024 Jul;13(7):1575-1588. doi: 10.1007/s40121-024-00992-5. Epub 2024 May 21.

Lipid Metabolism Modulation during SARS-CoV-2 Infection: A Spotlight on Extracellular Vesicles and Therapeutic Prospects.

Int J Mol Sci. 2024 Jan 4;25(1):640. doi: 10.3390/ijms25010640.

Is vaccine hesitancy related to mental health after the adjustment of the zero-COVID-19 strategy in the elderly? A mediation analysis in China.

Hum Vaccin Immunother. 2023 Dec 15;19(3):2288726. doi: 10.1080/21645515.2023.2288726. Epub 2023 Dec 6.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Suppr超能文献

New emerging SARS-CoV-2 variants and antiviral agents.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译